Abstract
The mainstays of antithrombotic therapy - aspirin, heparin, and warfarin - remain in the picture alongside some promising new arrivals. The search continues for better and safer ways to prevent new blood clots from forming and existing ones from growing.
Original language | English (US) |
---|---|
Pages (from-to) | 20-42 |
Number of pages | 23 |
Journal | Patient Care |
Volume | 34 |
Issue number | 15 |
State | Published - Dec 1 2000 |
ASJC Scopus subject areas
- Leadership and Management